Click Therapeutics Stock
Digital Therapeutics Applications
Sign up today and learn more about Click Therapeutics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Click Therapeutics Stock
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click’s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
Investors
Flatiron Investors
Magellan Health Services
K2 HealthVentures
Sanofi
Hikma Ventures
Funding History
June 2018 | $33.1M |
---|---|
October 2021 | $57.8M |
Management
Chief Executive Officer
David Benshoof Klein
Chief Technology Officer
Christopher Jordan
Press
patents - Apr, 15 2024
System and method for improving efficiency of a remote computing devicepatents - Apr, 15 2024
Platforms for dynamically selecting messages in real-time to users via decision …patents - Apr, 15 2024
Systems and methods for ensuring data security in the treatment of diseases and …patents - Apr, 15 2024
Dynamic selection of configuration files for applications in accordance with …patents - Apr, 15 2024
Provision of sessions with individually targeted visual stimuli to alleviate …